CytoMed Therapeutics (GDTC) Q4 2025 Earnings
GDTC·Reported May 4, 2026
CytoMed Therapeutics reported Q4 2025 revenue of $130.6K. Diluted EPS came in at $-0.11.
Revenue
$130.6K
Diluted EPS
$-0.11
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q4 2025 Earnings FAQ
Common questions about CytoMed Therapeutics's Q4 2025 earnings report.
CytoMed Therapeutics (GDTC) reported Q4 2025 earnings on May 4, 2026.
CytoMed Therapeutics reported revenue of $130.6K and diluted EPS of $-0.11 for Q4 2025.